Do you want to read an article? Please log in or register.
Visual Endoscopic Retrograde Appendicitis Therapy versus Antibiotic Therapy for Treatment of Uncomplicated Acute Appendicitis
Further Publications
Related content
Inflammatory Bowel Disease
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Lancet Gastroenterol Hepatol
Choy MC, Li Wai Suen CFD, Con D, Boyd K, Pena R, Burrell K, Rosella O, Proud D, Brouwer R, Gorelik A, Liew D, Connell WR, Wright EK, Taylor KM, Pudipeddi A, Sawers M, Christensen B, Ng W, Begun J, Radford-Smith G, Garg M, Martin N, van Langenberg DR, Ding NS, Beswick L, Leong RW, Sparrow MP, De Cruz P
doi: 10.1016/S2468-1253(24)00200-0
Helicobacter Pylori
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Helicobacter
Cheung KS, Lyu T, Deng Z, Han S, Ni L, Wu J, Tan JT, Qin J, Ng HY, Leung WK, Seto WK
doi: 10.1111/hel.13133
RECOMMENDED
Inflammatory Bowel Disease
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Lancet Gastroenterol Hepatol
ACCURE Study Group
doi: 10.1016/S2468-1253(25)00026-3
Hepatology
Endoscopic glue injection versus glue plus BRTO or TIPSS for preventing gastric variceal bleeding: A randomized controlled trial
Clin Gastroenterol Hepatol
Biswas S, Vaishnav M, Gamanagatti S, Swaroop S, Arora U, Aggarwal A, Elhence A, Gunjan D, Kedia S, Mahapatra SJ, Mishra AK, Shalimar
doi: 10.1016/j.cgh.2024.06.023
Inflammatory Bowel Disease
Immunogenicity and efficacy of subcutaneous infliximab monotherapy versus combination therapy in IBD: a systematic review and meta-analysis
Clin Gastroenterol Hepatol
Anjie SI, Gecse KB, Meloni CM, Vidal-Itriago A, Löwenberg M, D'Haens GR
doi: 10.1016/j.cgh.2025.03.021
Inflammatory Bowel Disease
Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
Adv Ther
Zhdanava M, Kachroo S, Boonmak P, Burbage S, Shah A, Korsiak J, Lefebvre P, Kerner C, Pilon D
doi: 10.1007/s12325-024-02942-6
Inflammatory Bowel Disease
Rescue Therapies for Steroid-Refractory Acute Severe Ulcerative Colitis: A Systemic Review and Network Meta-analysis
J Crohns Colitis
Huang CW, Yen HH, Chen YY
doi: 10.1093/ecco-jcc/jjae111
Further Publications
A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch
Am J Gastroenterol
Barnes EL, Raffals L, Qazi T, Deepak P, Chang S, Beniwal-Patel P, Higgins PD, Cross RK, Barr JI, Anderson C, Long MD, Herfarth HH, Dubinsky M, Kappelman MD, Kayal M
doi: 10.14309/ajg.0000000000003608
COMMENTED
Inflammatory Bowel Disease
Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis
★ 3
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Inflamm Intest Dis
Grob F, Häberling I, Novacek G, Kreienbühl A, Biedermann L, Rogler G, Schreiner P
doi: 10.1159/000546511